CMBA
USNA icon

C.M. Bidwell & Associates’s Usana Health Sciences USNA Stock Holding History

C.M. Bidwell & Associates’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-705
Closed -$83K – 476
2018
Q4 		$83K Buy
705
+365
+107% +$42.2K 0.09% 197
2018
Q3 		$41K Buy
+340
New +$42.2K 0.04% 244

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
JIM
Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

C.M. Bidwell & Associates's USNA Position: Q1 2019 in Review

C.M. Bidwell & Associates sold out of Usana Health Sciences (USNA) in Q1 2019, closing a stake of 705 shares — an estimated $83K sold.

C.M. Bidwell & Associates first reported a position in USNA in Q3 2018 and held it in 2 quarters. The position peaked at $83K in Q4 2018. 188 funds tracked by Wall St. Rank hold USNA as of Q1 2019.

  • C.M. Bidwell & Associates reported no remaining Usana Health Sciences position as of Q1 2019 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 705 Usana Health Sciences shares in Q1 2019, an estimated $83K.
  • C.M. Bidwell & Associates first reported a position in Usana Health Sciences in Q3 2018 and held it in 2 quarters.
  • C.M. Bidwell & Associates's Usana Health Sciences position peaked at $83K in Q4 2018.
  • 188 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2019.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2019, filed 15 May 2019.